| MDL | - |
|---|---|
| Molecular Weight | 393.91 |
| Molecular Formula | C20H28ClN3O3 |
| SMILES | NC1(C(N[C@@H](CC)/C=C/C(N2CCC3=C2C=CC=C3)=O)=O)CCOCC1.[H]Cl |
GSK-2793660 is a cathepsin C (also known as dipeptidyl peptidase I enzyme) inhibitor for the reaearch of cystic fibrosis, non-cystic fibrosis bronchiectasis, anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and bronchiectasis [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT02058407 | GlaxoSmithKline |
Bronchiectasis
|
January 28, 2014 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 100 mg/mL ( 253.87 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.5387 mL | 12.6933 mL | 25.3865 mL |
| 5 mM | 0.5077 mL | 2.5387 mL | 5.0773 mL |
| 10 mM | 0.2539 mL | 1.2693 mL | 2.5387 mL |